Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Immunol ; 167(8): 4271-5, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11591749

ABSTRACT

T cell anergy is characterized by the inability of the T cell to produce IL-2 and proliferate. It is reversible by the addition of exogenous IL-2. A similar state of unresponsiveness is observed when the proliferative response of murine CD4(+)CD25(-) T cells is suppressed in vitro by coactivated CD4(+)CD25(+) T cells. We have developed a suppression system that uses beads coated with anti-CD3 and anti-CD28 Abs as surrogate APCs to study the interaction of CD4(+)CD25(+) and CD4(+)CD25(-) T cells in vitro. CD4(+)CD25(+) T cell-induced suppression, in this model, was not abrogated by blocking the B7-CTLA-4 pathway. When the CD4(+)CD25(-) T cells were separated from the CD4(+)CD25(+) suppressor cells after 24 h of coactivation by the Ab-coated beads, the CD4(+)CD25(-) T cells were unable to proliferate or to produce IL-2 upon restimulation. The induction of this anergic phenotype in the CD4(+)CD25(-) T cells correlated with the up-regulated expression of the gene related to anergy in lymphocytes (GRAIL), a novel anergy-related gene that acts as a negative regulator of IL-2 transcription. This system constitutes a novel mechanism of anergy induction in the presence of costimulation.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Clonal Anergy/immunology , Immunoconjugates , Receptors, Interleukin-2/immunology , T-Lymphocyte Subsets/immunology , Abatacept , Animals , Antigen-Presenting Cells , Antigens, CD , Antigens, Differentiation , CD4-Positive T-Lymphocytes/drug effects , CTLA-4 Antigen , Coculture Techniques , Interleukin-2/pharmacology , Lymphocyte Activation , Mice , Mice, Inbred DBA , Signal Transduction , T-Lymphocyte Subsets/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL